TF-PROTACs Enable Targeted Degradation of Transcription Factors

Liu, Jing, Chen, He, Kaniskan, H. Ümit, Xie, Ling, Chen, Xian, Jin, Jian, Wei, Wenyi·2021·Journal of the American Chemical Society
DOI 10.1021/jacs.1c03852

Cited by (251)

Items 201–251 of 251

  1. The importance of controls in targeted protein degradation: Determining mechanism
    Brianna Hill-Payne, Sebastian Dilones, George M. Burslem · 2022 · Methods in enzymology on CD-ROM/Methods in enzymology
  2. High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression
    Linda M S Resar, Li Luo · 2025 · International Journal of Molecular Sciences
  3. PROTACs: Opportunities and Challenges Ahead in the Field of Drug Discovery
    Anish Kizhakkekkara Vadukoot · 2022 · International Journal of Medicine and Public Health
  4. Targeted i6A-RNA degradation through sequential Fluorination-Azidation and Click reaction with imidazole-based probes
    Yuyang Guo, Xiaoqian Chen, Youfang Gan, Yuanyuan Li, Rui Wang · 2024 · Bioorganic & Medicinal Chemistry Letters
  5. The First‐In‐Class Deubiquitinase‐Targeting Chimera Stabilizes and Activates cGAS
    Zhijie Deng, Li Chen, Chao Qian, Jing Liu, Qiong Di Wu, Xiangyang Song, Yan Xiong, Zhen Wang, Xiaoping Hu, Hiroyuki Inuzuka et al. · 2024 · Angewandte Chemie
  6. Functionalized DNA secondary structures and nanostructures for specific protein modifications
    Bauke Albada · 2024 · Trends in Biochemical Sciences
  7. Design, synthesis and evaluation of pyrrolobenzodiazepine (PBD)-based PROTAC conjugates for the selective degradation of the NF-κB RelA/p65 subunit
    Peiqin Jin, Md. Mahbub Hasan, Andrea G. S. Pepper, Simon A. Mitchell, Khondaker Miraz Rahman, Chris J. Pepper · 2025 · RSC Medicinal Chemistry
  8. Proteolysis Targeting Chimera (PROTACs) in Cancer: From Molecular Mechanisms to Therapeutic Opportunities
    Jing Yang, Qing Qiao, Na Lin, Miaomiao Niu, Lin Su, Boshu Yin · 2025 · Journal of Biochemical and Molecular Toxicology
  9. Engineered anchoring aptamers induce relocalization and functional inactivation of transcription factors
    Neng Ling, Hui Wu, Yibin Zhang, Shuang Yao, Fangyu Liu, X. H. Tang, Tiantian Xie, Yijun Yuan, Xianhua Wei, Jing Dai et al. · 2026 · Science Advances
  10. Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation
    Takafumi Furuhata, Kazuki Yoshida, 藤田 凌嘉, Jotaro Miyamoto, Chiharu Moriyama, Tokiha Masuda-Ozawa, Hikaru Tsuchiya, Yasushi Saeki, Akimitsu Okamoto · 2026 · Communications Chemistry
  11. Arylidene-Thiazoldione Scaffold Acts as the E3 Ligand of DCAF11 for PROTAC Design
    Jinyi Liang, Yuyang Liu, Man Zhao, Lu Chen, Jiajie Qin, Wenjing Ma, Yue Wang, Haiqiang Wu, Ruilin Tian, Tianzi Wei et al. · 2026 · Journal of Medicinal Chemistry
  12. Accelerating the Discovery of Targeted Protein Degraders: Advances in Synthetic Methodologies and Screening Tactics
    Baoli Ding, Xiaotong Chen, Yulu Chen, Ji Cao, Bo Yang, Li Jiang, Cheng‐Liang Zhu · 2026 · Chemistry - A European Journal
  13. Bifunctional proximity-inducing strategies for targeted and programmable post-translational modifications
    Sadiya Tanga, Pallabi Das, Tuhin Baran Samoi, Arpita Hota, Arkadeep Karmakar, Basudeb Maji · 2026 · Advanced Drug Delivery Reviews
  14. PAX3::FOXO1-Targeting PROTAC Induces Myogenic Differentiation of Fusion-Positive Rhabdomyosarcoma Cells
    Nikola Knoll, Kayra Somay, Purushottam Babu Tiwari, Emre Deniz, Jeffrey S. S. K. Formen, Isabel Frye, Eryn Nelson, Christian Wolf, Jeffrey A. Toretsky, Aykut Üren · 2026 · Cancers
  15. State‐of‐the‐Art Nrf2 Inhibitors: Therapeutic Opportunities in Non‐Cancer Diseases
    Emil G. Ayala‐Cosme, Deborah J. Yang, Kyara Vences, Lindsey O. Davis, Matteo Borgini · 2024 · ChemMedChem
  16. Membrane‐Bounded Intracellular E3 Ubiquitin Ligase‐Targeting Chimeras (MembTACs) for Targeted Membrane Protein Degradation
    Mengwu Mo, Feiyu Wang, Huimin Zhang, Ying Zhang, Chaoyong James Yang, Jinbiao Shang, Zhi Zhu · 2025 · Angewandte Chemie
  17. GRHL3 specifically initiated by the TP63 transcription factor promotes the metastasis of squamous cell carcinogenesis
    Hanyu Bai, Xiaojian Wei, Yan Xi, Sisi Wei, Suli Dai, Dachi Wang, Yongxian Xue, Debnarayan Jana, Feng Gao, Wei Zhou et al. · 2025 · Cellular Signalling
  18. WITHDRAWN: Targeted protein degradation: A promising approach for cancer treatment
    Muhammad Zafar Irshad Khan, Adila Nazli, Iffat Naz, Dildar Khan, Ihsan‐ul Haq, Jianzhong Chen · 2023 · Journal of Pharmaceutical Analysis · Retracted
  19. Targeting Transcription Factors for Degradation
    Dirk H. Trauner, Matthew McLarney DiCairano · 2021 · Synfacts
  20. O bi namo ma ronga isi go Galelaka / ditulis Etha Yosafat ; diindonesiakan Robinon Ipol
    Yosafat Etha · 1985
  21. E2F1 activation by oncogenic FLT3 internal tandem duplication in regulating purine metabolism in acute myeloid leukaemia
    Feihu Chen, Ziyao Ou, Ke Wang, Wenwen Shen, Ge Deng, Yayun Xu, Longfei Wang, Zhuoyan Zai, Yian Ling, Tao Zhang et al. · 2022 · Research Square
  22. The Future of Heterobifunctional Compounds: PROTACs and Beyond
    George M. Burslem · 2022 · Wiley eBooks
  23. New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery
    Eric Valeur · 2023 · Royal Society of Chemistry eBooks
  24. Structural Considerations and Chemistry of PROTACs
    Abhishek Wahi, Hemant R. Jadhav, Shikha Thakur, Sushma Dev, Priyanka Mohanty, Priti Jain · 2024 · Springer eBooks
  25. Computational modelling of aggressive B-cell lymphoma
    Eleanor S. Jayawant, Aimilia Vareli, Andrea G. S. Pepper, Chris J. Pepper, Fabio A. Simoes, Simon A. Mitchell · 2025 · Biochemical Society Transactions
  26. Degradation of G‐Quadruplex‐Binding Proteins by G4L‐PROTAC via Quaternary Complex Formation
    Rena Nohara, Yuma Tanaya, Mohammad Jafar Sheikhi, Pratiksha Chaudhary, Grinsun Sharma, Hanbin Mao, Kazuo Nagasawa, Masayuki Tera · 2025 · Angewandte Chemie
  27. PROTAC-mediated regulation of programmed cell death: From molecular mechanisms to therapeutic breakthroughs
    Hangqi Huang, Aoli Deng, Feifan Pan, Yajuan Lu, Lulu Chen, Jinghao Cao, Qin Tang, Yingchao Liu, Yunyi Wu, Jing Du et al. · 2026 · The Innovation
  28. Nucleoside-ATTEC Conjugates for Targeting Inhibition of HIV Replication and Infection
    Xiaofeng Liao, Kaifu Zhang, Chu Wang, Mengmeng Liu, Jinsong Ren, Xiaogang Qu · 2026 · Journal of Medicinal Chemistry
  29. Towards the long-term, conditional and tractable disruption of Notch3 signaling in zebrafish neural stem and progenitor cells
    Mathilde Chouly · 2024
  30. Anticancer, Antitumor, and Antioxidant Microbial Lipids: Mechanism of Action, Production, and Clinical Application
    Morteza Nadeb, Seyed Soheil Aghaei, Tahereh Komeili-Movahed, Hamed Afkhami · 2026 · Oxidative Medicine and Cellular Longevity
  31. HOXD10 promotes hepatocellular carcinoma progression by enhancing m6A methylation and activating the PI3K/AKT/mTOR pathway
    秦承东, Xinyi Gao, Siyuan Liu, Jiejie Hu, Lihong Hu, Chao Hu, Yang Yu, De-Ning Ma · 2026 · Journal of Translational Medicine
  32. Mapping Scientific Landscapes and Therapeutic Innovations of Targeted Protein Degradation: A Scientometric Review
    Chong Li, Xiang-Xiu Wang, An-Qi He, Tianjie Bao, Wei-Hua Zhuang, Cheng-Qi He, Yong-Hong Yang · 2026 · Pharmaceutics
  33. The Diverse Roles of the MEF2 Transcription Factor Family in Tumor Progression and Emerging Therapeutic Opportunities
    Yanyan Chen, Jingni Zhu, Jinghang Qian, Sheng Li, Yang Liu · 2026 · Biomedicines
  34. Targeted protein degradation: mechanistic diversity, therapeutic expansion, and clinical translation
    Caiyu Wang, Zhibin Guo, Yufei Liu, Qichao Gao, Qing Wang, Yi Liu, Yujiao Liu · 2026 · International Journal of Pharmaceutics
  35. Mechanobiology and Molecular Regulation of Periodontal Tissue Remodeling During Orthodontic Tooth Movement: From Periodontal Phenotype to Precision Orthodontics—A Narrative Review
    Bartłomiej Górski, Edyta Kalina, Marcin Derwich · 2026 · International Journal of Molecular Sciences
  36. PROTAC as a Potential Toolbox for the Discovery of New Targets and Drugs
    Mengjun Ma, Xiaolei Meng, Chong Qin · 2026 · Handbook of experimental pharmacology
  37. Branched DNA Nanoplatform-Based Multivalent PROTACs for Tumor Microenvironment-Responsive Degradation of Telomere-Binding Proteins in Tumor Therapy
    Hanyin Zhu, Xintong Li, Hong Wang, Huarui Liu, Dandan Li, Changping Yang, Baoquan Ding, Jianbing Liu · 2026 · Nano Letters
  38. A mini-review of the molecular mechanisms, mutational landscape, and therapeutic opportunities of TWIST1 in oncology
    Bruno Ricardo Barreto Pires, Gerson Moura Ferreira, Eliana S. F. W. Abdelhay · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  39. Chemically Induced Proximity for Targeted Protein O- GlcNAcylation
    Bowen Ma, Tongyang Xu, Zhihao Guo, Wai‐Lung Ng · 2026 · Accounts of Chemical Research
  40. Protein degraders targeting JAK/STAT3 signaling pathway are emerging therapeutic modalities for human cancers
    Xinyu Feng, Nanjing Li, Xiaorong Chen, Xinyue Cao, Jingling Dai, Shaoquan Xiong, Zhu Yuan · 2026 · Biochemical Pharmacology
  41. Self‐Reporting Hierarchical DNA Nanoplatform for Tumor Cell‐Selective Senescence Modulation and Immune Remodeling
    Wenya Dang, Jun Da, Jun Cao, Haolan Hu, Yuqi Xie, Lu Yu, Lu Wu, Linlin Wang, Jili Li, Yanlan Liu · 2026 · Small Methods
  42. Centromere-Targeting Chimeras for Combating Cancer Drug Resistance
    Dingpeng Zhang, Zhen Wang, William W. Feng, Wenyun Zhang, Xutong Xue, Yan Xiong, Xing Gao, Hiroyuki Inuzuka, Jeanelle Tsai, Jiaqi Li et al. · 2026 · Journal of Medicinal Chemistry
  43. BindingDB Entry 50020161: Advances of bioorthogonal coupling reactions in drug development.
    BindingDB · 2024 · UC San Diego
  44. BindingDB Entry 50016839: VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives.
    BindingDB · 2023 · UC San Diego
  45. BindingDB Entry 50017503: Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity.
    BindingDB · 2023 · UC San Diego
  46. BindingDB Entry 50016515: Nucleic-Acid-Based Targeted Degradation in Drug Discovery.
    BindingDB · 2023 · UC San Diego
  47. BindingDB Entry 50016429: Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond.
    BindingDB · 2023 · UC San Diego
  48. BindingDB Entry 50021731: Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader.
    BindingDB · 2025 · UC San Diego
  49. BindingDB Entry 50023360: PROTAC technology: From drug development to probe technology for target deconvolution.
    BindingDB · 2026 · UC San Diego
  50. BindingDB Entry 50020717: A beginner's guide to current synthetic linker strategies towards VHL-recruiting PROTACs.
    BindingDB · 2024 · UC San Diego
  51. BindingDB Entry 50021132: Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders.
    BindingDB · 2025 · UC San Diego